Immunocore is probably the only company in the world that has developed a way of harnessing the power of the immune system’s natural-born killer cells: the T-cells to fight cancer. In the video below watch melanoma cancer cells (red) being killed by T cells (blue) when activated by the drug, IMCgp100 (a melanoma specific ImmTAC) designed by the company. Healthy cells (green) are ignored and left undamaged.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments